Page last updated: 2024-08-23

captopril and dalteparin

captopril has been researched along with dalteparin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, A; Chou, WY; Ho, YS; Lee, WH; Lin, YF; Sheu, LF; Wang, JY	1
Balkwill, F; Blann, AD; Caine, GJ; Christodoulos, K; Dobbs, N; Ganesan, TS; Gompertz, N; Harris, AL; Jones, PH; Kakkar, AJ; Kumar, S; Talbot, DC; Thavasu, P	1
Blann, AD; Caine, GJ; Christodoulos, K; Harris, AL; Lip, GY	1

Trials

1 trial(s) available for captopril and dalteparin

Article	Year
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer. British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Dalteparin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinolytic Agents; Humans; Hydroxamic Acids; Injections, Subcutaneous; Lymphocytes; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Treatment Outcome; Tumor Necrosis Factor-alpha	2004

Article

Year

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.

British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Dalteparin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinolytic Agents; Humans; Hydroxamic Acids; Injections, Subcutaneous; Lymphocytes; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Treatment Outcome; Tumor Necrosis Factor-alpha

2004

Other Studies

2 other study(ies) available for captopril and dalteparin

Article	Year
Administration of dexamethasone induces proteinuria of glomerular origin in mice. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticoagulants; Blood Glucose; Blood Urea Nitrogen; Captopril; Complement C3; Creatinine; Dalteparin; Dexamethasone; Female; Glucocorticoids; Hematuria; Immunoglobulins; Kidney; Kidney Glomerulus; Mice; Mice, Inbred BALB C; Proteinuria; Serum Albumin; Ultrasonography	1998
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer. Cancer letters, 2005, Mar-10, Volume: 219, Issue:2 Topics: Adult; Aged; Angiogenesis Inhibitors; Anticoagulants; Captopril; Dalteparin; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; P-Selectin; Platelet Activation; Thromboplastin; Vascular Endothelial Growth Factor A	2005

Article

Year

Administration of dexamethasone induces proteinuria of glomerular origin in mice.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:3

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticoagulants; Blood Glucose; Blood Urea Nitrogen; Captopril; Complement C3; Creatinine; Dalteparin; Dexamethasone; Female; Glucocorticoids; Hematuria; Immunoglobulins; Kidney; Kidney Glomerulus; Mice; Mice, Inbred BALB C; Proteinuria; Serum Albumin; Ultrasonography

1998

Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.

Cancer letters, 2005, Mar-10, Volume: 219, Issue:2

Topics: Adult; Aged; Angiogenesis Inhibitors; Anticoagulants; Captopril; Dalteparin; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; P-Selectin; Platelet Activation; Thromboplastin; Vascular Endothelial Growth Factor A

2005